BioCryst Pharmaceuticals shares owned by Lazard Asset Management
Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Lazard Asset Management
from 13F filings
Historical chart of Lazard Asset Management investment in BioCryst Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including BioCryst Pharmaceuticals held by Lazard Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in BioCryst Pharmaceuticals by Lazard Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $730k | 96k | 7.60 |
| 2024-03-31 | $66k | 13k | 5.01 |
| 2023-12-31 | $84k | 14k | 5.94 |
| 2023-03-31 | $29k | 3.6k | 8.13 |
| 2022-12-31 | $40k | 3.6k | 11.21 |
| 2022-09-30 | $44k | 3.6k | 12.34 |
| 2022-06-30 | $37k | 3.6k | 10.37 |
| 2022-03-31 | $57k | 3.6k | 15.98 |
| 2021-09-30 | $46k | 3.2k | 14.21 |
| 2020-03-31 | $35k | 18k | 2.00 |